» Articles » PMID: 37014698

Polarized Localization of Phosphatidylserine in the Endothelium Regulates Kir2.1

Abstract

Lipid regulation of ion channels is largely explored using in silico modeling with minimal experimentation in intact tissue; thus, the functional consequences of these predicted lipid-channel interactions within native cellular environments remain elusive. The goal of this study is to investigate how lipid regulation of endothelial Kir2.1 - an inwardly rectifying potassium channel that regulates membrane hyperpolarization - contributes to vasodilation in resistance arteries. First, we show that phosphatidylserine (PS) localizes to a specific subpopulation of myoendothelial junctions (MEJs), crucial signaling microdomains that regulate vasodilation in resistance arteries, and in silico data have implied that PS may compete with phosphatidylinositol 4,5-bisphosphate (PIP2) binding on Kir2.1. We found that Kir2.1-MEJs also contained PS, possibly indicating an interaction where PS regulates Kir2.1. Electrophysiology experiments on HEK cells demonstrate that PS blocks PIP2 activation of Kir2.1 and that addition of exogenous PS blocks PIP2-mediated Kir2.1 vasodilation in resistance arteries. Using a mouse model lacking canonical MEJs in resistance arteries (Elnfl/fl/Cdh5-Cre), PS localization in endothelium was disrupted and PIP2 activation of Kir2.1 was significantly increased. Taken together, our data suggest that PS enrichment to MEJs inhibits PIP2-mediated activation of Kir2.1 to tightly regulate changes in arterial diameter, and they demonstrate that the intracellular lipid localization within the endothelium is an important determinant of vascular function.

Citing Articles

Sickle Trait and Alpha Thalassemia Increase NOS-Dependent Vasodilation of Human Arteries Through Disruption of Endothelial Hemoglobin-eNOS Interactions.

Brooks S, Ruhl A, Zeng X, Cruz P, Hassan S, Kamenyeva O Circulation. 2024; 151(1):8-30.

PMID: 39633569 PMC: 11670920. DOI: 10.1161/CIRCULATIONAHA.123.066003.


Endothelial-adipocyte Cx43 Mediated Gap Junctions Can Regulate Adiposity.

Luse M, Dunaway L, Nyshadham S, Carvalho A, Sedovy M, Ruddiman C Function (Oxf). 2024; 5(5).

PMID: 38984993 PMC: 11384900. DOI: 10.1093/function/zqae029.


Visceral adipose of obese mice inhibits endothelial inwardly rectifying K channels in a CD36-dependent fashion.

Rokka S, Sadeghinejad M, Hudgins E, Johnson E, Nguyen T, Fancher I Am J Physiol Cell Physiol. 2024; 326(5):C1543-C1555.

PMID: 38586877 PMC: 11371330. DOI: 10.1152/ajpcell.00073.2024.


Obesogenic diet disrupts tissue-specific mitochondrial gene signatures in the artery and capillary endothelium.

Dunaway L, Luse M, Nyshadham S, Bulut G, Alencar G, Chavkin N Physiol Genomics. 2023; 56(2):113-127.

PMID: 37982169 PMC: 11281809. DOI: 10.1152/physiolgenomics.00109.2023.

References
1.
Tikku S, Epshtein Y, Collins H, Travis A, Rothblat G, Levitan I . Relationship between Kir2.1/Kir2.3 activity and their distributions between cholesterol-rich and cholesterol-poor membrane domains. Am J Physiol Cell Physiol. 2007; 293(1):C440-50. DOI: 10.1152/ajpcell.00492.2006. View

2.
Wilson C, Zhang X, Lee M, MacDonald M, Heathcote H, Alorfi N . Disrupted endothelial cell heterogeneity and network organization impair vascular function in prediabetic obesity. Metabolism. 2020; 111:154340. PMC: 7538703. DOI: 10.1016/j.metabol.2020.154340. View

3.
Lopes C, Zhang H, Rohacs T, Jin T, Yang J, Logothetis D . Alterations in conserved Kir channel-PIP2 interactions underlie channelopathies. Neuron. 2002; 34(6):933-44. DOI: 10.1016/s0896-6273(02)00725-0. View

4.
Ahn S, Fancher I, Bian J, Zhang C, Schwab S, Gaffin R . Inwardly rectifying K channels are major contributors to flow-induced vasodilatation in resistance arteries. J Physiol. 2016; 595(7):2339-2364. PMC: 5374117. DOI: 10.1113/JP273255. View

5.
Ahn S, Fancher I, Granados S, Do Couto N, Hwang C, Phillips S . Cholesterol-Induced Suppression of Endothelial Kir Channels Is a Driver of Impairment of Arteriolar Flow-Induced Vasodilation in Humans. Hypertension. 2021; 79(1):126-138. PMC: 8845492. DOI: 10.1161/HYPERTENSIONAHA.121.17672. View